Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

50.63 +3.13 (+6.59%)
Streaming Delayed Price Updated: 2:00 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,045,633
Open 50.43
Bid (Size) 50.56 (1)
Ask (Size) 50.71 (1)
Prev. Close 47.50
Today's Range 46.56 - 54.98
52wk Range 4.450 - 51.21
Shares Outstanding 54,865,673
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street
UniQure NV (NASDAQ: QURE) just staged one of biotech's wildest rides of the year, soaring 248% in a single session after unveiling successful trial results for its experimental Huntington's disease... 
Via Benzinga
CrowdStrike To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga

Performance

YTD
+180.5%
+180.5%
1 Month
+225.6%
+225.6%
3 Month
+253.3%
+253.3%
6 Month
+270.9%
+270.9%
1 Year
+885.0%
+885.0%

More News

Read More
uniQure Stock Jumps On Positive News, But Risks Remain
Via Benzinga
Wall Street Pauses AI Frenzy as Oracle Seeks $15B in Fresh Funding
Via Chartmill
Topics Artificial Intelligence
Earnings Scheduled For July 29, 2025
Via Benzinga
Alibaba, Intel, Uniqure, Tesla And Opendoor: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
UniQure Stock Hits 5-Year High As Analysts Hail Huntington’s Therapy Data — Retail Spots ‘Diamond In Rough Of Biotech’
Via Stocktwits
uniQure Announces $200 Million Proposed Public Offering
From uniQure Inc.
Via GlobeNewswire
Nasdaq Down Over 100 Points; US Crude Oil Stocks Fall
Via Benzinga
What's Going On With UniQure Stock Wednesday?
Via Benzinga
Lithium Americas, Alibaba, uniQure, IREN, Cidara: Stocks Making The Biggest Moves Today
Via Stocktwits
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
A Cure For Huntington's Disease? UniQure Launches More Than 240%.
Via Investor's Business Daily
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial
Via Benzinga
uniQure Stock Rises Pre-Market After Investigational Huntington’s Disease Drug Slows Disease In Trial
Via Stocktwits
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
From uniQure Inc.
Via GlobeNewswire
uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
uniQure's Investigational Gene Therapy Shows Promising Efficacy With Manageable Safety Risks For Fabry Disease
Via Benzinga
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
From uniQure Inc.
Via GlobeNewswire
FDA Outlines Process To Speed Up Rare Disease Therapy Approvals
Via Benzinga
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
Via Benzinga
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
Via Benzinga
uniQure Narrows Loss in Fiscal Q2
Via The Motley Fool
uniQure NV (NASDAQ:QURE) Posts Q2 2025 Earnings: EPS Beat Offsets Revenue Miss as Regulatory Progress Boosts Shares
Via Chartmill
uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
From uniQure Inc.
Via GlobeNewswire

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?
Yes, uniQure N.V. - Ordinary Shares is publicly traded.
What exchange does uniQure N.V. - Ordinary Shares trade on?
uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for uniQure N.V. - Ordinary Shares?
The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market
What is the current price of uniQure N.V. - Ordinary Shares?
The current price of uniQure N.V. - Ordinary Shares is 50.63
When was uniQure N.V. - Ordinary Shares last traded?
The last trade of uniQure N.V. - Ordinary Shares was at 09/25/25 02:00 PM ET
What is the market capitalization of uniQure N.V. - Ordinary Shares?
The market capitalization of uniQure N.V. - Ordinary Shares is 2.78B
How many shares of uniQure N.V. - Ordinary Shares are outstanding?
uniQure N.V. - Ordinary Shares has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.